Strategic Partnerships Pangaea Data has active and high-profile partnerships with Sanofi, AstraZeneca, and Microsoft, signaling strong credibility and potential co-sell opportunities to access large pharma pipelines and clinical trial networks.

Clinical Efficiency Their platform focuses on identifying untreated and sub-optimally treated patients by mimicking clinician workflows with explainable AI, offering health systems a path to close care gaps, reduce costs, and improve revenue through expanded patient screening and engagement.

AI Platform Growth The October 2025 platform launch and ongoing AI integration with Dragon Copilot and NVIDIA tech suggest upsell potential for expanded AI capabilities, data processing scaling, and broader analytics services for pharma and providers.

Investment & Validation Significant funding and grants, including a major $110 million LLM in Medicine grant and a $300M+ funding track, provide validation for sales narratives around innovation, risk mitigation, and long-term collaboration potential.

Market Expansion Recent press coverage of partnerships with Sanofi and AstraZeneca indicates a proven interest from global pharma to leverage their patient-finding and trial-matching capabilities, opening doors for regional deployments and managed services engagements.